CMCC-Retained Rights Sample Clauses

CMCC-Retained Rights. The license granted in Section 2.1 of this Agreement is subject to, and expressly limited by, CMCC's non-exclusive rights to make and use, and to grant to other research and educational institutions (each, a "THIRD PARTY RESEARCHER"), subject to their prior written agreement to be bound by the terms and conditions of this Section 2.2, a non-exclusive license to make and use, the technology and the subject matter described and claimed in the PATENT RIGHTS for research and educational purposes only, whether or not such activities are sponsored by or otherwise paid for by or performed in conjunction with or on behalf of any commercial entity (the "CMCC RETAINED RIGHTS")
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
CMCC-Retained Rights. The license granted in Section 2.1 of this Agreement is subject to, and expressly limited by, CMCC's non-exclusive rights to make and use, and to grant to other research and educational institutions (each, a "THIRD PARTY RESEARCHER"), subject to their prior written agreement to be bound by the terms and conditions of this Section 2.2, a non-exclusive license to make and use, the technology and the subject matter described and claimed in the PATENT RIGHTS for research and educational purposes only, whether or not such activities are sponsored by or otherwise paid for by or performed in conjunction with or on behalf of any commercial entity (the "CMCC RETAINED RIGHTS") 2.2.2 Option(s) to Celgene on THALIDOMIDE INVENTIONS . If, in the exercise of the CMCC RETAINED RIGHTS, CMCC or any THIRD PARTY RESEARCHER makes any potentially patentable inventions or discoveries -9- <PAGE> relating to THALIDOMIDE or to PRODUCTS ("THALIDOMIDE INVENTION"), including without limitation any modifications to any PRODUCT or any improvement to any of the THALIDOMIDE PATENT RIGHTS or any MIXED PATENT THALIDOMIDE CLAIMS, CMCC shall, and CMCC shall contractually obligate any such THIRD PARTY RESEARCHER to, promptly notify CELGENE and BIOVENTURE in writing, provided that the notice to BIOVENTURE need not contain any confidential technical information. CMCC hereby grants, and shall contractually obligate each such THIRD PARTY RESEARCHER to grant, CELGENE an exclusive option ("Option") to enter into a license agreement granting CELGENE an exclusive, worldwide, royalty-bearing license, with the right to sublicense, under any patent applications and patents directed to such THALIDOMIDE INVENTION, to make, have made, use, lease, offer for sale, sell, and import PRODUCTS and practice methods in the FIELD. 2.2.3 Exercise of Option(s). The term of each Option granted to CELGENE hereunder shall run and be exercisable independently on a THALIDOMIDE INVENTION-by-THALIDOMIDE INVENTION basis, beginning on the date on which CELGENE receives notice thereof pursuant to Section 2.2.2 and continuing for a period of three (3) months ("Option Period"). In the event that this Agreement terminates during any Option Period(s) for any reason other than due to CELGENE's breach of this Agreement, each such Option Period, and the rights and obligations of the parties under Sections 2.2.3, 2.2.4 and 2.2.5 with respect to the relevant THALIDOMIDE INVENTION, shall continue in full force and effect for the duration...
Sample 1

Related to CMCC-Retained Rights

  • Retained Rights The Contributor or, if applicable, the Contributor’s Employer, retains all proprietary rights in addition to copyright, such as patent rights in any process, procedure or article of manufacture described in the Contribution.

  • Licensed Rights (a) (i) BNYM hereby grants to Company a limited, nonexclusive, nontransferable license to access and use the Licensed System in the United States through its employees (other than as expressly permitted otherwise by Section 2.1(a)(ii) below), solely in accordance with applicable Documentation, through the interfaces and telecommunication lines designated by BNYM, strictly for the internal business purposes of the Company, solely in support of the Core Services and solely for so long as any applicable fees are paid by Company.

  • Acquired Rights The Participant acknowledges and agrees that: (a) the Company may terminate or amend the Plan at any time; (b) the award of the Option made under this Agreement is completely independent of any other award or grant and is made at the sole discretion of the Company; (c) no past grants or awards (including, without limitation, the Option awarded hereunder) give the Participant any right to any grants or awards in the future whatsoever; and (d) any benefits granted under this Agreement are not part of the Participant’s ordinary salary, and shall not be considered as part of such salary in the event of severance, redundancy or resignation.

  • Reserved Rights (a) The state, for itself and others, reserves all rights not expressly granted to the lessee by this lease. These reserved rights include, but are not limited to:

  • Preserved Rights of Employee This Agreement does not waive or release any rights or claims that Employee may have under the Age Discrimination in Employment Act that arise after the execution of this Agreement. In addition, this Agreement does not prohibit Employee from challenging the validity of this Agreement’s waiver and release of claims under the Age Discrimination in Employment Act of 1967, as amended.

  • Unfunded Rights The right of the Participant to receive Common Stock pursuant to this Agreement is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this Agreement other than those of an unsecured general creditor of the Company.

  • Accrued Rights Termination or expiration of this Agreement for any reason shall be without prejudice to any rights that shall have accrued to the benefit of a Party prior to such termination or expiration. Such termination or expiration shall not relieve a Party from obligations that are expressly indicated to survive the termination or expiration of this Agreement.

  • No Implied Rights Nothing contained in this Section 13.1 shall be construed as obligating a Party to disclose its Confidential Information to the other Party, or as granting to or conferring on a Party, expressly or impliedly, any rights or license to any Confidential Information of the other Party.

  • Protected Rights The Company and the undersigned agree that nothing in this Separation Agreement and Release is intended to or shall be construed to affect, limit or otherwise interfere with any non-waivable right of the undersigned under any Federal, state or local law, including the right to file a charge or participate in an investigation or proceeding conducted by the Equal Employment Opportunity Commission (“EEOC”) or to exercise any other right that cannot be waived under applicable law. The undersigned is releasing, however, his/her right to any monetary recovery or relief should the EEOC or any other agency pursue Claims on his/her behalf. Further, should the EEOC or any other agency obtain monetary relief on his/her behalf, the undersigned assigns to the Company all rights to such relief.

Time is Money Join Law Insider Premium to draft better contracts faster.